Abstract: The present invention relates to novel insulin derivatives and their use in the treatment or prevention of medical conditions relating to diabetes. The insulin derivatives are glucose sensitive and display glucose-sensitive albumin binding. The insulin derivatives have a long half-life. The invention also relates to novel intermediates. Finally, the invention provides a pharmaceutical composition comprising the insulin derivatives of the invention and the use of such a composition in the treatment or prevention of medical conditions relating to diabetes.
| # | Name | Date |
|---|---|---|
| 1 | 202547114106-STATEMENT OF UNDERTAKING (FORM 3) [20-11-2025(online)].pdf | 2025-11-20 |
| 2 | 202547114106-Sequence Listing in PDF [20-11-2025(online)].pdf | 2025-11-20 |
| 3 | 202547114106-PROOF OF RIGHT [20-11-2025(online)].pdf | 2025-11-20 |
| 4 | 202547114106-PRIORITY DOCUMENTS [20-11-2025(online)].pdf | 2025-11-20 |
| 5 | 202547114106-POWER OF AUTHORITY [20-11-2025(online)].pdf | 2025-11-20 |
| 6 | 202547114106-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [20-11-2025(online)].pdf | 2025-11-20 |
| 7 | 202547114106-FORM 18 [20-11-2025(online)].pdf | 2025-11-20 |
| 8 | 202547114106-FORM 1 [20-11-2025(online)].pdf | 2025-11-20 |
| 9 | 202547114106-DRAWINGS [20-11-2025(online)].pdf | 2025-11-20 |
| 10 | 202547114106-COMPLETE SPECIFICATION [20-11-2025(online)].pdf | 2025-11-20 |